We are 2-(4-CHLOROPHENOXY)ANILINE CAS:2770-11-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.2-(3'-Chloro[1,1'-biphenyl]-3-yl)-4,6-diphenyl-1,3,5-triazine CAS:1443049-83-9 Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.2106-18-5 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.Tribromuro de piridinio CAS:39416-48-3 Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.Advanced clinical trials with the Company’s lead compound, rigosertib, are aimed at what the Company believes are unmet medical needs of patients with MDS.
Product Name | |
---|---|
[4-(N-phenylanilino)phenyl]boronic acid | View Details |
benzyl (2S,3aS,6aS)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrole-2-carboxylate,hydrochloride | View Details |
ac-asp(otbu)-oh | View Details |